ASIA BEAT: Japan gets feel-good, Taiwan makes NICE
This article was originally published in Scrip
Executive Summary
As Japan's pharma majors prepare to announce results generally in line with guidance for the nine months ended 31 December, investors' eyes are turning more to upside factors for the final quarter of the fiscal year on the back of new government policies.